Literature DB >> 21336967

P-glycoprotein enhances radiation-induced apoptotic cell death through the regulation of miR-16 and Bcl-2 expressions in hepatocellular carcinoma cells.

Tsun Yee Tsang1, Wan Yee Tang, Judy Yuet Wa Chan, Ngai Na Co, Chi Lam Au Yeung, Pak Lun Yau, Siu Kai Kong, Kwok Pui Fung, Tim Tak Kwok.   

Abstract

P-glycoprotein (Pgp), an efflux pump, was confirmed the first time to regulate the expressions of miR/gene in cells. Pgp is known to be associated with multidrug resistance. RHepG2 cells, the multidrug resistant subline of human hepatocellular carcinoma HepG2 cells, expressed higher levels of Pgp as well as miR-16, and lower level of Bcl-2 than the parental cells. In addition, RHepG2 cells were more radiation sensitive and showed more pronounced radiation-induced apoptotic cell death than the parental cells. Mechanistic analysis revealed that transfection with mdr1 specific antisense oligos suppressed radiation-induced apoptosis in HepG2 cells. On the other hand, ectopic mdr1 expression enhanced radiation-induced apoptosis in HepG2 cells, SK-HEP-1 cells, MiHa cells, and furthermore, induced miR-16 and suppressed its target gene Bcl-2 in HepG2 cells. Moreover, the enhancement effects of Pgp and miR-16 on radiation-induced apoptosis were counteracted by overexpression of Bcl-2. The Pgp effect on miR-16/Bcl-2 was suppressed by Pgp blocker verapamil indicating the importance of the efflux of Pgp substrates. The present study is the first to reveal the role of Pgp in regulation of miRNA/gene expressions. The findings may provide new perspective in understanding the biological function of Pgp.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336967     DOI: 10.1007/s10495-011-0581-5

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  7 in total

1.  Plasma microRNAs to predict the response of radiotherapy in esophageal squamous cell carcinoma patients.

Authors:  Qi Yu; Bingxin Li; Ping Li; Zeliang Shi; Amanda Vaughn; Liucun Zhu; Shen Fu
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

2.  MicroRNAs and cancer: Key paradigms in molecular therapy.

Authors:  Weige Tan; Bodu Liu; Shaohua Qu; Gehao Liang; Wei Luo; Chang Gong
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

Review 3.  DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.

Authors:  Sumadi Lukman Anwar; Ulrich Lehmann
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

4.  Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Wen Wang; Lan Juan Zhao; Ye-Xiong Tan; Hao Ren; Zhong-Tian Qi
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

5.  MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.

Authors:  Wen Wang; Lan-Juan Zhao; Ye-Xiong Tan; Hao Ren; Zhong-Tian Qi
Journal:  Carcinogenesis       Date:  2012-02-23       Impact factor: 4.944

6.  Association between MDR1 gene of gastrointestinal tumors, the expression of P-glycoprotein and resistance to chemotherapeutic drugs.

Authors:  Jian-Li Su; Cheng-Hong Wang; Hong-Gang Kang; Jing Zhang; Bao-Zhong Wang; Mei-Rong Liu; Jun Zhao; Lin Liu
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

7.  [Establishment of animal model of a human lung adenocarcinoma drug-resistant
cell line Anip973/NVB and investigation on mechanism of drug resistance].

Authors:  Meng Wang; Xuan Hong; Qinwen Sun; Ruilin Li; Zhaoyang Yang; Gongyan Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.